- Home
- ESRT vs OPK Comparison
ESRT vs OPK Comparison
Compare ESRT & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESRT
- OPK
- Stock Information
- Founded
- ESRT 2011
- OPK 2007
- Country
- ESRT United States
- OPK United States
- Employees
- ESRT N/A
- OPK N/A
- Industry
- ESRT Real Estate Investment Trusts
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- ESRT Real Estate
- OPK Health Care
- Exchange
- ESRT Nasdaq
- OPK Nasdaq
- Market Cap
- ESRT 1.2B
- OPK 1.0B
- IPO Year
- ESRT 2013
- OPK 1995
- Fundamental
- Price
- ESRT $7.67
- OPK $1.41
- Analyst Decision
- ESRT Hold
- OPK Buy
- Analyst Count
- ESRT 2
- OPK 4
- Target Price
- ESRT $10.65
- OPK $2.75
- AVG Volume (30 Days)
- ESRT 1.4M
- OPK 2.6M
- Earning Date
- ESRT 07-23-2025
- OPK 07-31-2025
- Dividend Yield
- ESRT 1.82%
- OPK N/A
- EPS Growth
- ESRT N/A
- OPK N/A
- EPS
- ESRT 0.24
- OPK N/A
- Revenue
- ESRT $763,746,000.00
- OPK $664,029,000.00
- Revenue This Year
- ESRT $3.48
- OPK N/A
- Revenue Next Year
- ESRT $2.79
- OPK $6.98
- P/E Ratio
- ESRT $32.10
- OPK N/A
- Revenue Growth
- ESRT 1.14
- OPK N/A
- 52 Week Low
- ESRT $6.56
- OPK $1.11
- 52 Week High
- ESRT $11.62
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- ESRT 54.83
- OPK 59.51
- Support Level
- ESRT $7.25
- OPK $1.22
- Resistance Level
- ESRT $7.56
- OPK $1.40
- Average True Range (ATR)
- ESRT 0.19
- OPK 0.05
- MACD
- ESRT 0.05
- OPK 0.01
- Stochastic Oscillator
- ESRT 88.62
- OPK 95.45
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.